gvtcx

NHS National Pharmaceuticals Transition 2021_3

NHS England Published 4 Nov 2021 Contracts Finder

key details

Value£25,983,607
Statuscomplete
Category (CPV) 33600000
RegionEast Midlands, East of England, London, North East, North West, South East, South West, West Midlands, Yorkshire and the Humber
Deadline7 Jul 2021
Contract start1 Oct 2021
Contract end31 May 2024
Procedureopen
SME suitableYes
OCIDocds-b5fd17-d87b195f-23f2-4420-b141-6d1b0d6ffb05

Awards (36)

This procurement was awarded to 36 suppliers. Values shown are per-award; the notice total is £25,983,607.

SupplierValueDateStatus
Accord-UK Ltd shared £25,983,607 21 Oct 2021 active
Aguettant Ltd shared £25,983,607 21 Oct 2021 active
Alturix shared £25,983,607 21 Oct 2021 active
Amarox Limited shared £25,983,607 21 Oct 2021 active
Ambe Medical Group Ltd shared £25,983,607 21 Oct 2021 active
Aspen Pharmacare UK Limited shared £25,983,607 21 Oct 2021 active
Aspire Pharma Limited shared £25,983,607 21 Oct 2021 active
Brown & Burk UK Ltd shared £25,983,607 21 Oct 2021 active
Cipla (EU) Ltd shared £25,983,607 21 Oct 2021 active
Colonis Pharma Ltd shared £25,983,607 21 Oct 2021 active
Consilient Health Ltd shared £25,983,607 21 Oct 2021 active
CST Pharma Limited shared £25,983,607 21 Oct 2021 active
Day Lewis Medical Ltd shared £25,983,607 21 Oct 2021 active
Dr.Reddy's Laboratories (UK) Limited shared £25,983,607 21 Oct 2021 active
Drugsrus Ltd shared £25,983,607 21 Oct 2021 active
Glenmark Pharmaceuticals Europe Limited shared £25,983,607 21 Oct 2021 active
Kensington Pharma Ltd shared £25,983,607 21 Oct 2021 active
Kent Pharma Ltd shared £25,983,607 21 Oct 2021 active
Laboratorio Reig Jofre SA shared £25,983,607 21 Oct 2021 active
Lucane Pharma shared £25,983,607 21 Oct 2021 active
Macure Pharma ApS shared £25,983,607 21 Oct 2021 active
medac Pharma LLP shared £25,983,607 21 Oct 2021 active
Mercury Pharmaceuticals Limited shared £25,983,607 21 Oct 2021 active
Morningside Pharmaeuticals shared £25,983,607 21 Oct 2021 active
Mylan shared £25,983,607 21 Oct 2021 active
Napp Pharmaceuticals Ltd shared £25,983,607 21 Oct 2021 active
Panpharma UK Limited shared £25,983,607 21 Oct 2021 active
Pfizer Ltd shared £25,983,607 21 Oct 2021 active
Ranbaxy UK shared £25,983,607 21 Oct 2021 active
Roche Products Ltd shared £25,983,607 21 Oct 2021 active
Seacross Pharmaceuticals Ltd shared £25,983,607 21 Oct 2021 active
Teva UK Limited shared £25,983,607 21 Oct 2021 active
Thornton and Ross Ltd shared £25,983,607 21 Oct 2021 active
Torbay Pharmaceuticals shared £25,983,607 21 Oct 2021 active
Wockhardt UK Limited shared £25,983,607 21 Oct 2021 active
Zentiva Pharma UK Ltd shared £25,983,607 21 Oct 2021 active

description

NHS National PharmaceuticalsTransition 2021_3

Offer reference number:CM/PHG/21/5633

documents

Documents are linked, not mirrored. They are served by the publishing authority and may require registration.

notice history

2 notices published against this procurement.

PublishedTypeRegimeNotice
2 Jun 2021 Tender (tender) · f97be428-75da-4735-bbe8-9f497359ec16-440869
4 Nov 2021 Award (award) · ba019c4f-4fb5-4224-ab4f-172c2129003c-482778

more from NHS England

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.